Celsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates

Provided By Globe Newswire

Last update: May 10, 2022

PLACCINE DNA-based Vaccine in proof-of-concept non-Human Primate Studies

Phase II study of GEN-1 in ovarian cancer 85% enrolled with full enrollment expected in the third quarter of 2022